These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 6655441)

  • 61. Plasma and tissue binding considerations in drug disposition.
    Wilkinson GR
    Drug Metab Rev; 1983; 14(3):427-65. PubMed ID: 6347593
    [No Abstract]   [Full Text] [Related]  

  • 62. [Age as a factor in dose-response relationship of drugs].
    Gundert-Remy U
    Z Gerontol Geriatr; 1995; 28(6):408-14. PubMed ID: 8581759
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Dosage of drugs with regard to their distribution volume and biological half-life].
    Dahl SG
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1201-2. PubMed ID: 4839999
    [No Abstract]   [Full Text] [Related]  

  • 64. Computer-calculated kanamycin dosage regimen and monitoring.
    Ritschel WA; Banarer M; Lau-Chang EF
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):121-5. PubMed ID: 844931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. STRIPACT, an interactive curve fit programme for pharmacokinetic analyses.
    Leferink JG; Maes RA
    Arzneimittelforschung; 1979; 29(12):1894-8. PubMed ID: 546430
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estimation of drug dosage regimens with a pharmacokinetic slide rule.
    Straughn AB; Cruze CA; Meyer MC
    Am J Hosp Pharm; 1977 Feb; 34(2):197-200. PubMed ID: 842548
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Altered pharmacokinetics in old age: consequences for cytostatic therapy].
    Gribnau FW
    Tijdschr Gerontol Geriatr; 1986 Apr; 17(2):55-8. PubMed ID: 3715963
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics of aspirin and its application in canine veterinary medicine.
    Morton DJ; Knottenbelt DC
    J S Afr Vet Assoc; 1989 Dec; 60(4):191-4. PubMed ID: 2487727
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Individualization of drug therapy: history, present state, and opportunities for the future.
    Lesko LJ; Schmidt S
    Clin Pharmacol Ther; 2012 Oct; 92(4):458-66. PubMed ID: 22948891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.
    Turnheim K
    Eur J Clin Pharmacol; 1991; 40(1):87-93. PubMed ID: 2060552
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Customizing dosage drugs what contribution in therapeutic drug monitoring?].
    Abdessadek M; Magoul R; Amarti A; El Ouezzani S; Khabbal Y
    Ann Biol Clin (Paris); 2014; 72(1):15-24. PubMed ID: 24492095
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic drug monitoring in pharmacovigilance and pharmacotherapy safety.
    Haen E
    Pharmacopsychiatry; 2011 Sep; 44(6):254-8. PubMed ID: 21959787
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Meta-analysis of research on the effect of clinical pharmacokinetics services on therapeutic drug monitoring.
    Ried LD; McKenna DA; Horn JR
    Am J Hosp Pharm; 1989 May; 46(5):945-51. PubMed ID: 2729302
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
    Klotz U
    Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Problems in dose finding from the view of the clinical pharmacologist (author's transl)].
    Weber E
    Arzneimittelforschung; 1977 Feb; 27(2A):264-72. PubMed ID: 577173
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetic changes in the elderly.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 Mar; 9(3):161-6. PubMed ID: 3298892
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.
    Lee CS; Marbury TC
    Clin Pharmacokinet; 1984; 9(1):42-66. PubMed ID: 6362952
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quantitative relationships between dynamics and kinetics of drugs: a systems dynamics approach.
    van Rossum JM; Burgers JP
    Drug Metab Rev; 1984; 15(1-2):365-82. PubMed ID: 6378560
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Model building in pharmacokinetics/Part V: Simulation of blood level curves following repetitive dosing and their experimental verification (author's transl)].
    Hammer R; Bozler G; Heinzel G; Koss FW
    Arzneimittelforschung; 1977; 27(4a):928-31. PubMed ID: 577860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.